Indy Star interviewed Thomas F. Imperiale, M.D., about his study published in the New England Journal of Medicine. This next generation multi-target stool DNA colorectal cancer screening test detects 94 percent of colorectal cancers and has the best performance for detection of both colorectal cancer and advanced precancerous polyps of any noninvasive colorectal cancer screening test.
-
Research
- Experts
In The News
View All
AP News features LOINC
LOINC, developed and maintained by the Regenstrief Institute, was featured by AP...
Influence
View All
Primary Care and Survival: Implications for Research and Policy
Published in the Journal of General Internal Medicine. Here is a link...
- About
Regenstrief is dedicated to pioneering transformative solutions for a healthier world.
- The Latest
- Experts